-
FGFR3 Inhibition in SLC26A2 Chondrodysplasia
2026-08-24
The reference study combines genetic models, chondrocyte assays, and pharmacological intervention to show that excessive FGFR3 signaling contributes to SLC26A2-related skeletal dysplasia. Its findings support NVP-BGJ398 as a research tool for testing FGFR3 pathway inhibition, while also highlighting the limits of translating mouse growth-plate results directly to human treatment.
-
Rifampin as a Translational Tool for Bacterial Transcription
2026-08-24
Rifampin is more than a bactericidal antibiotic: it is a precise perturbation tool for connecting bacterial RNA polymerase activity with resistance, transcriptional regulation, and synthetic biology outcomes. This article outlines how translational researchers can use its mechanism, handling profile, and experimental limitations to build stronger evidence packages.
-
IDH1-R132H Autopalmitoylation in Cancer
2026-08-23
The reference study identifies C269 autopalmitoylation as a mutation-specific regulator of IDH1-R132H, linking fatty-acid availability to 2-HG-producing activity, dimerization, and oncogenic phenotypes. Its combination of chemical-probe profiling, cysteine mutagenesis, biochemical assays, and cellular validation provides a mechanistic framework for studying a druggable hydrophobic pocket in IDH1-mutant cancers.
-
NEDD4L, PRMT5, and Colorectal Cancer Liver Metastasis
2026-08-22
The reference study identifies the HECT E3 ligase NEDD4L as a suppressor of colorectal cancer liver metastasis through targeted degradation of PRMT5. Its in vivo E3-ligase screen and mechanistic validation connect NEDD4L to reduced AKT1 arginine methylation and inhibition of AKT/mTOR signaling, providing a framework for studying metastasis-associated protein stability.
-
Solanesol B8776: Practical Workflow Guide
2026-08-22
Solanesol B8776 is a hydrophobic polyisoprenoid alcohol for controlled membrane-related, enzyme, and cell-based research workflows. It should be prepared in DMSO and handled as a fresh solution; it is unsuitable for water- or ethanol-based systems and is not intended for diagnostic, clinical, or medical use.
-
nor-NOHA: Arginase Workflows for Cancer Research
2026-08-21
Build mechanistic cancer and vascular assays around nor-NOHA acetate, a reversible arginase perturbation that connects arginine availability with nitric oxide biology. The workflow pairs direct arginase readouts with invasion, apoptosis, endothelial, and AML immune-metabolism assays while keeping CD36 findings experimentally distinct.
-
PRRSV N Protein, Caspase-6, and IFN Evasion
2026-08-20
The reference study identifies a host–virus mechanism in which caspase-6 cleaves the PRRSV nucleocapsid protein at the conserved D94 site, weakening IRF3-dependent interferon responses and enhancing viral replication. Reverse-genetic disruption of this site produced an attenuated virus with stronger innate immune activation, providing a mechanistic basis for antiviral targeting and rational live-attenuated vaccine design.
-
BMX-IN-1: From Kinase Signal to Lysosomal Control
2026-08-20
BMX-IN-1 is a selective, irreversible BMX kinase inhibitor for dissecting kinase-dependent cell fate and lysosomal acidification. This guide translates recent Mycobacterium tuberculosis findings into practical assay strategies while defining the compound’s value and limitations in cancer and infection research.
-
Cholesterol in mRNA-LNP Workflows
2026-08-19
Learn how Cholesterol can serve as a controlled variable in membrane fluidity assays, lipid metabolism research, and mRNA-lipid nanoparticle development. This practical guide connects solvent handling and formulation controls with the localized p21 mRNA-LNP strategy reported for bladder cancer, while separating published findings from optimization recommendations.
-
BIBR 1532: A Mechanistic Map of Telomere Stress
2026-08-19
BIBR 1532 is a selective telomerase inhibitor that helps distinguish direct hTERT suppression from downstream telomere damage and apoptosis. This article integrates BIBR 1532 with the CF10–EdU telomere-attrition model to provide a more rigorous framework for cancer-cell assays.
-
Biotin-HPDP for Reversible Thiol Labeling
2026-08-18
Biotin-HPDP is a sulfhydryl-reactive reagent for selective, reversible labeling of free cysteine thiols. Its disulfide-linked biotin supports protein biotinylation for affinity purification, streptavidin-based detection, and controlled reductive release.
-
FOXM1 Autophagic Degradation and Chemoresistance
2026-08-18
The reference study used gene network analysis to identify STL427944, a compound that suppresses the oncogenic transcription factor FOXM1 by moving it from the nucleus to the cytoplasm and promoting autophagic degradation. This mechanism increased cancer-cell sensitivity to platinum drugs, 5-fluorouracil, and taxanes, offering a selective strategy for addressing chemotherapy resistance.
-
EdU Cell Proliferation Kit: From Signal to Mechanism
2026-08-17
The EdU Cell Proliferation Kit links direct DNA-synthesis measurement with mechanistic interpretation of cell-cycle biology. This guide shows how to use a 5-ethynyl-2'-deoxyuridine proliferation assay to validate transcriptomic findings, evaluate drug responses, and avoid overinterpreting bulk proliferation signals.
-
NEDD4L, PRMT5, and Colorectal Cancer Liver Metastasis
2026-08-17
The reference study identifies the E3 ligase NEDD4L as a suppressor of colorectal cancer liver metastasis and establishes PRMT5 as a previously unrecognized NEDD4L substrate. Its data connect NEDD4L-dependent PRMT5 degradation with reduced AKT1 arginine methylation and inhibition of AKT/mTOR signaling, providing a mechanistic framework for studying metastatic colonization.
-
CP-673451: Selective PDGFRα/β Inhibitor Workflows
2026-08-16
CP-673451 enables focused interrogation of PDGFRα/β signaling, from rapid phosphorylation assays to PDGF-BB-driven angiogenesis and xenograft studies. Its selectivity profile also supports genotype-aware cancer research, including experiments that compare ATRX-deficient and ATRX-proficient glioma models.